期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Pathologic response to preoperative transarte- rial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection 被引量:3
1
作者 Kwang Yeol Paik Eung Kook Kim 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS CSCD 2016年第2期122-124,共3页
Hepatocellular carcinoma (HCC) is one of the most frequent complications in patients with .liver cirrhosis. HCC without cirrhosis is rareand obviously a different entity. Treatment depends on tumor stage, liver func... Hepatocellular carcinoma (HCC) is one of the most frequent complications in patients with .liver cirrhosis. HCC without cirrhosis is rareand obviously a different entity. Treatment depends on tumor stage, liver function and general performance. Results of locoregional treatment, resection or liver transplantation are superior to those of medical therapy. Surgical approaches are potentially curative. Underlying cirrhosis is usually the limiting factor for the extent of resection and persists after resection. Liver transplantation eliminates both cirrhosis and, potentially, the tumor. Whereas surgery (functional liver capacity provided) may be performed even in advanced tumors, liver transplantation is advocated in less advanced (T2) tumors in order to keep the rate of recurrent tumor low. Responsible use of scarce grafts requires sticking to this rule. 展开更多
关键词 recurrence cirrhosis preoperative frequent extrahepatic cirrhotic dissemination potentially metastases necrotic
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部